Although we have presented prior evidence that high IGFBP7 expression by breast cancer tissue or high circulating levels of this protein are related to poor prognosis28,29, this protein has not previously been studied in relation to the efficacy of IGF-1R targeted therapies. The gene discussed is IGF1R; the disease is breast carcinoma.